Icosavax Inc.

NASDAQ: ICVX · Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM

Icosavax Revenue Breakdown

Period Ending Dec 31, 2022 Dec 31, 2021
Grant Revenue 600K 9.4M
Grant Revenue Growth -93.62% n/a

Operating Expense Breakdown

Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 8.61M 9.13M 9.16M 8.94M 7.66M 7.31M 6.32M 6.22M 25.36M 2.22M 1.09M 802K 704K 541K 612K
Selling, General, and Administrative Revenue Growth -5.72% -0.39% +2.54% +16.70% +4.76% +15.64% +1.67% -75.48% +1041.69% +103.57% +36.03% +13.92% +30.13% -11.60% n/a
Research and Development Revenue 16.67M 19.83M 17.36M 16.19M 15.48M 15.82M 17.91M 14.06M 10.88M 8.28M 5.55M 5.33M 4.75M 4.67M 2.92M
Research and Development Revenue Growth -15.93% +14.22% +7.19% +4.58% -2.12% -11.68% +27.38% +29.22% +31.48% +49.05% +4.20% +12.14% +1.84% +59.79% n/a